Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 7 September 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 209 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is N and Author is Garcia Rodriguez, L. A.  [Clear All Filters]
Journal Article
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., Graffner, H., and Dent, J., Natural history of gastro-oesophageal reflux disease diagnosed in general practice, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
H. Jick, Derby, L. E., Rodriguez, L. A. Garcia, Jick, S. S., and Dean, A. D., Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
C. Huerta, Castellsague, J., Varas-Lorenzo, C., and Rodriguez, L. A. Garcia, Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
C. Huerta, Varas-Lorenzo, C., Castellsague, J., and Rodriguez, L. A. Garcia, Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population, Heart, vol. 92, pp. 1610-5, 2006.
M. A. Hernan, Logroscino, G., and Rodriguez, L. A. Garcia, Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease, Neurology, vol. 66, pp. 1097-9, 2006.
L. A. Garcia Rodriguez and Hernandez-Diaz, S., Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure, Epidemiology, vol. 14, pp. 240-6, 2003.
[Page last reviewed 7 September 2020]